In response to these problems, the consensus on the Ki67 assessment 2021 edition (the International Breast Cancer Ki67 Working Group) clearly pointed out that Artificial Intelligence (AI) assistive and automation scoring may be a feasible solution to the main points of Ki67 assessment [8]. Here, MKI67 is linked to breast cancer.